What is Bicara Therapeutics's granted (in shares)?

Bicara Therapeutics (BCAX) reported granted (in shares) of $16.79 in Q1 2026.

What does granted (in shares) mean?

The weighted average exercise price of stock options granted to employees and directors during the reporting period. This metric reflects the company's cost of equity-based incentives and the strike price set for new option awards.

Bicara Therapeutics BCAX Granted (in shares)

Granted (in shares) at other companies

RepligenRGEN

$125.03—

Proto LabsPRLB

$62.63+58.1%

AvePoint, Inc.AVPT

$10.52—

Ivanhoe ElectricIE

$13.50-3.3%

Atlanticus Holdings CorporationATLC

$0.00—

VestisVSTS

$15.78-18.7%

Other financials

Income statement

See full

Operating income-$60.2M-44.2%

Net income-$56.2M-52.6%

EPS (diluted)-$0.93-36.8%

Balance sheet

See full

Cash & equivalents$323.5M-30.0%

Total debt$1.4M+144%

Total equity$514.0M+12.0%

Total assets$553.6M+15.8%

Cash flow

See full

Operating cash flow-$37.5M-33.5%

CapEx$60.0K—

Free cash flow-$37.6M-33.7%

Valuation

See full

Market cap$1.68B+81.4%

Returns & leverage

See full

Return on equity-32.3%—

Debt / equity0×0.0×

Current ratio13.9×-10.8×

Where this comes from

Reported directly by Bicara Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice.

The official record: Bicara Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bicara Therapeutics's granted (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bicara Therapeutics's granted (in shares)?: Bicara Therapeutics (BCAX) reported granted (in shares) of $16.79 in Q1 2026.
What does granted (in shares) mean?: The weighted average exercise price of stock options granted to employees and directors during the reporting period. This metric reflects the company's cost of equity-based incentives and the strike price set for new option awards.